Wednesday, February 15, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 4

If you are unable to see the message below, click here to view.
British Journal of Cancer

Advertisement
Nature Outlook: Kidney Cancer

Kidney cancer has long flown under the radar despite being one of the top-ten cancer killers worldwide. It remains hard to detect, difficult to treat and poorly understood. But that is starting to change as researchers dig into the mysteries surrounding the disease. 

Access the Outlook free online for six months

Produced with support from:

TABLE OF CONTENTS

Volume 116, Issue 4 (415-551)
Published online 14 February 2017

In this issue
Review
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics & Genomics
Epidemiology
Index

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Review

Top

Giving AXL the axe: targeting AXL in human malignancy

Carl M Gay, Kavitha Balaji and Lauren Averett Byers

Br J Cancer 2017 116: 415-423; advance online publication, January 10, 2017; 10.1038/bjc.2016.428

Abstract | Full Text

Clinical Studies

Top

Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre

Olusola O Faluyi, Joanna L Connor, Madhuchanda Chatterjee, Carl Ikin, Helen Wong and Daniel H Palmer

Br J Cancer 2017 116: 424-431; advance online publication, January 12, 2017; 10.1038/bjc.2016.406

Abstract | Full Text

Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma

Adil Daud, Harriet M Kluger, Razelle Kurzrock, Frauke Schimmoller, Aaron L Weitzman, Thomas A Samuel, Ali H Moussa, Michael S Gordon and Geoffrey I Shapiro

Br J Cancer 2017 116: 432-440; advance online publication, January 19, 2017; 10.1038/bjc.2016.419

Abstract | Full Text

Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance

Philip Johnson, Sarah Berhane, Chiaki Kagebayashi, Shinji Satomura, Mabel Teng, Richard Fox, Winnie Yeo, Frankie Mo, Paul Lai, Stephen L Chan, Toshifumi Tada, Hidenori Toyoda and Takashi Kumada

Br J Cancer 2017 116: 441-447; advance online publication, January 12, 2017; 10.1038/bjc.2016.422

Abstract | Full Text

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion

Imam Waked, Sarah Berhane, Hidenori Toyoda, Stephen L Chan, Nicholas Stern, Daniel Palmer, Toshifumi Tada, Winnie Yeo, Frankie Mo, Dominik Bettinger, Martha M Kirstein, Mercedes Iñarrairaegui, Asmaa Gomaa, Arndt Vogel, Tim Meyer, Bruno Sangro, Paul Lai, Takashi Kumada and Philip J Johnson

Br J Cancer 2017 116: 448-454; advance online publication, January 26, 2017; 10.1038/bjc.2016.423

Abstract | Full Text

Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist)

Kristina Lindemann, Emma Gibbs, Elisabeth Åvall-Lundqvist, Rene dePont Christensen, Kathrine Woie, Marten Kalling, Annika Auranen, Seija Grenman, Thomas Hoegberg, Per Rosenberg, Tone Skeie-Jensen, Elisabet Hjerpe, Anne Dørum, Val Gebski and Gunnar Kristensen

Br J Cancer 2017 116: 455-463; advance online publication, January 24, 2017; 10.1038/bjc.2016.435

Abstract | Full Text

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer

T Ioka, Y Komatsu, N Mizuno, A Tsuji, S Ohkawa, M Tanaka, H Iguchi, A Ishiguro, M Kitano, T Satoh, T Yamaguchi, K Takeda, M Kida, K Eguchi, T Ito, M Munakata, T Itoi, J Furuse, C Hamada and Y Sakata

Br J Cancer 2017 116: 464-471; advance online publication, January 12, 2017; 10.1038/bjc.2016.436

Abstract | Full Text

A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO)

P S Hall, S R Lord, M Collinson, H Marshall, M Jones, C Lowe, H Howard, D Swinson, G Velikova, A Anthoney, R Roy, J Dent, S Cheeseman, K Last and M T Seymour

Br J Cancer 2017 116: 472-478; advance online publication, January 17, 2017; 10.1038/bjc.2016.442

Abstract | Full Text

Translational Therapeutics

Top

Radiation-induced lung metastasis development is MT1-MMP-dependent in a triple-negative breast cancer mouse model

Gina Bouchard, Hélène Therriault, Sameh Geha, Rachel Bujold, Caroline Saucier and Benoit Paquette

Br J Cancer 2017 116: 479-488; advance online publication, January 19, 2017; 10.1038/bjc.2016.448

Abstract | Full Text

Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance

B Englinger, M Mair, W Miklos, C Pirker, T Mohr, S van Schoonhoven, D Lötsch, W Körner, F Ferk, S Knasmüller, P Heffeter, B K Keppler, M Grusch and W Berger

Br J Cancer 2017 116: 489-500; advance online publication, January 17, 2017; 10.1038/bjc.2016.449

Abstract | Full Text

Molecular Diagnostics

Top

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples

Anna Kazarian, Oleg Blyuss, Gergana Metodieva, Aleksandra Gentry-Maharaj, Andy Ryan, Elena M Kiseleva, Olga M Prytomanova, Ian J Jacobs, Martin Widschwendter, Usha Menon and John F Timms

Br J Cancer 2017 116: 501-508; advance online publication, January 12, 2017; 10.1038/bjc.2016.433

Abstract | Full Text

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy

Takeo Fujii, Takahiro Kogawa, Jimin Wu, Aysegul A Sahin, Dian D Liu, Mariana Chavez-MacGregor, Sharon H Giordano, Akshara Raghavendra, Rushmy K Murthy, Debu Tripathy, Yu Shen, Jose-Miguel Yamal and Naoto T Ueno

Br J Cancer 2017 116: 509-514; advance online publication, January 12, 2017; 10.1038/bjc.2016.444

Abstract | Full Text

Comparative mutational landscape analysis of patient-derived tumour xenografts

Mariana Brait, Evgeny Izumchenko, Luciane T Kagohara, Samuel Long, Piotr T Wysocki, Brian Faherty, Elana J Fertig, Tin Oo Khor, Elizabeth Bruckheimer, Gilson Baia, Daniel Ciznadija, Ido Sloma, Ido Ben-Zvi, Keren Paz and David Sidransky

Br J Cancer 2017 116: 515-523; advance online publication, January 24, 2017; 10.1038/bjc.2016.450

Abstract | Full Text

Genetics & Genomics

Top

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

Siddhartha P Kar, Emily Adler, Jonathan Tyrer, Dennis Hazelett, Hoda Anton-Culver, Elisa V Bandera, Matthias W Beckmann, Andrew Berchuck, Natalia Bogdanova, Louise Brinton, Ralf Butzow, Ian Campbell, Karen Carty, Jenny Chang-Claude, Linda S Cook, Daniel W Cramer, Julie M Cunningham, Agnieszka Dansonka-Mieszkowska, Jennifer Anne Doherty, Thilo Dörk, Matthias Dürst, Diana Eccles, Peter A Fasching, James Flanagan, Aleksandra Gentry-Maharaj, Rosalind Glasspool, Ellen L Goode, Marc T Goodman, Jacek Gronwald, Florian Heitz, Michelle A T Hildebrandt, Estrid Høgdall, Claus K Høgdall, David G Huntsman, Allan Jensen, Beth Y Karlan, Linda E Kelemen, Lambertus A Kiemeney, Susanne K Kjaer, Jolanta Kupryjanczyk, Diether Lambrechts, Douglas A Levine, Qiyuan Li, Jolanta Lissowska, Karen H Lu, Jan Lubiński, Leon F A G Massuger, Valerie McGuire, Iain McNeish, Usha Menon, Francesmary Modugno, Alvaro N Monteiro, Kirsten B Moysich, Roberta B Ness, Heli Nevanlinna, James Paul, Celeste L Pearce, Tanja Pejovic, Jennifer B Permuth, Catherine Phelan, Malcolm C Pike, Elizabeth M Poole, Susan J Ramus, Harvey A Risch, Mary Anne Rossing, Helga B Salvesen, Joellen M Schildkraut, Thomas A Sellers, Mark Sherman, Nadeem Siddiqui, Weiva Sieh, Honglin Song, Melissa Southey, Kathryn L Terry, Shelley S Tworoger, Christine Walsh, Nicolas Wentzensen, Alice S Whittemore, Anna H Wu, Hannah Yang, Wei Zheng, Argyrios Ziogas, Matthew L Freedman, Simon A Gayther, Paul D P Pharoah and Kate Lawrenson

Br J Cancer 2017 116: 524-535; advance online publication, January 19, 2017; 10.1038/bjc.2016.426

Abstract | Full Text

Epidemiology

Top

The burden of occupationally-related cutaneous malignant melanoma in Britain due to solar radiation

Lesley Rushton and Sally J Hutchings

Br J Cancer 2017 116: 536-539; advance online publication, January 17, 2017; 10.1038/bjc.2016.437

Abstract | Full Text

Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis

Jason D Pole, Paul Gibson, Marie-Chantal Ethier, Tanya Lazor, Donna L Johnston, Carol Portwine, Mariana Silva, Sarah Alexander and Lillian Sung on behalf of the International Pediatric Oncology Mortality Classification (IPOMC) Group

Br J Cancer 2017 116: 540-545; advance online publication, January 17, 2017; 10.1038/bjc.2016.443

Abstract | Full Text

Index

Top

Referee Acknowledgement for 2016

Br J Cancer 2017 116: 546-551; 10.1038/bjc.2017.16

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: